June 2026
The global targeted DNA RNA sequencing market size is estimated to hit around USD 80.78 billion by 2035, increasing from USD 14.28 billion in 2025, with a CAGR of 18.92%.
April 2026
The U.S. targeted DNA RNA sequencing market size is accounted to hit around USD 27.72 billion by 2035 increasing from USD 4.80 billion in 2025, with a CAGR of 19.17%.
November 2025
The global DNA sequencing market size reached USD 14.70 billion in 2025 and is projected to reach around USD 51.31 billion by 2034 with a soild CAGR of 14.90%.
July 2025
The global DNA forensics market size was valued at USD 2.79 billion in 2024 and is projected to attain around USD 5.87 billion by 2034, with a CAGR of 7.18%.
June 2026
The global recombinant DNA technology market size was valued at USD 913.36 billion in 2025 and is expected to hit around USD 1,719.89 billion by 2035, at a CAGR of 6.53%.
June 2026
The global pet DNA testing market size was valued at USD 447.94 million in 2025 and is expected to hit around USD 1,177.22 million by 2035, growing at a CAGR of 10.14% from 2026 to 2035.
June 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
June 2026
The global RNA editing market size was valued at USD 15.95 billion in 2025 and is expected to surpass around USD 27.79 billion by 2035, growing at a CAGR of 5.71% from 2026 to 2035.
June 2026
The U.S. DNA nanotechnology market size is accounted to hit around USD 18.03 billion by 2035 increasing from USD 2.01 billion in 2025, with a CAGR of 24.53%.
June 2026
The RNA editing therapies market expands with clinical progress in precision therapeutics, rare disease solutions, and gene-based medicine.
June 2026
The global DNA nanotechnology market size was exhibited at USD 6.88 billion in 2025 and is predicted to surpass around USD 60.27 billion by 2035, with a solid CAGR of 24.24%.
June 2026
The global single cell sequencing market size is estimated to hit around USD 11.09 billion by 2035, increasing from USD 2.82 billion in 2025, with a CAGR of 14.67%.
June 2026
The US DNA synthesis market size was evaluated at USD 1.90 billion in 2025 and is predicted to hit around USD 10.66 billion by 2035, growing at a CAGR of 18.82%.
June 2026
The mRNA vaccines and therapeutics market size reached USD 116.88 billion in 2025 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
June 2026
The global DNA repair drugs market size reached USD 9.36 billion in 2025 and is predicted to surpass around USD 33.11 billion by 2035 with a notable CAGR of 13.47%.
June 2026
The US viral vectors and plasmid DNA manufacturing market size is valued at USD 3.30 billion in 2025 and is predicted to hit USD 11.69 billion by 2035, with a CAGR of 15.20%.
June 2026
The global targeted therapeutics market size was estimated at USD 85.75 billion in 2025 and is projected to hit around USD 163.91 billion by 2035 with a CAGR of 6.69%.
June 2026
The global whole exome sequencing market size was evaluated at USD 551.13 million in 2025 and is predicted to hit around USD 3,014.19 million by 2035, growing at a CAGR of 18.52%.
May 2026
The global external ventricular drain market size was valued at USD 7.77 billion in 2025 and is projected to hit around USD 13.47 billion by 2035 with a CAGR of 5.66%.
May 2026
The mRNA therapeutics market size was valued at USD 20.83 billion in 2025 and is expected to hit around USD 45.40 billion by 2035, growing at a CAGR of 8.1%.
May 2026
The global next-generation sequencing market is valued at USD 15.53 billion in 2025 and is expected to surpass around USD 66.95 billion by 2035 with a remarkable CAGR of 15.73% from 2026 to 2035.
May 2026
The viral vectors and plasmid DNA manufacturing market size is expected to hit USD 29.82 billion by 2035 from USD 7.26 billion in 2025 with a CAGR of 15.17%.
May 2026
The plasmid DNA manufacturing market size was estimated at USD 2.64 billion in 2025 and is expected to hit around USD 12.45 billion by 2035, growing at a CAGR of 16.78%.
May 2026
The U.S. plasmid DNA manufacturing market size was exhibited at USD 810 million in 2025 and is projected to hit USD 4,003 million by 2035, at a CAGR of 18.41%.
May 2026
The global AI in healthcare governance and safety market size was evaluated at USD 2.40 billion in 2025 and is predicted to hit around USD 19.65 billion by 2035, growing at a CAGR of 23.40%.
May 2026
The global mRNA synthesis raw materials market size was evaluated at USD 2.22 billion in 2025 and is predicted to hit around USD 8.37 billion by 2035, growing at a CAGR of 14.21 %.
May 2026
The global DNA-based non-viral technologies market size was evaluated at USD 5.60 billion in 2025 and is predicted to hit around USD 27.85 billion by 2035, growing at a CAGR of 17.40%.
April 2026
The global AI ethics and governance solutions market size was evaluated at USD 1.90 billion in 2025 and is predicted to hit around USD 23.51 billion by 2035, growing at a CAGR of 28.60%.
April 2026
The global next-generation sequencing technologies market size is estimated to hit around USD 48.76 billion by 2035 increasing from USD 12.00 billion in 2025, with a CAGR of 15.05%.
April 2026
The global B-cell maturation antigen (BCMA) targeted therapies market size was evaluated at USD 5.60 billion in 2025 and is predicted to hit around USD 29.81 billion by 2035, growing at a CAGR of 18.20%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com